International Cannabis Weekly: 123
- Cannabis stocks rebound as US Congressional committee passes the MORE Act.
- Cannabis Europa launches thought leadership conference in Madrid.
- Liberal Democrats’ manifesto pledges to legalise cannabis in the UK.
- Australian Senate launches inquiry to address patient barriers to medical cannabis.
- Thai health minister pushes for home-cultivation.
- Aurora halts construction on Denmark facility to stem losses.
- Germany aligns with EU CBD ruling on ‘Novel Food’.
- MEP for Malta calls for standardised EU medical cannabis regulations.
- Khiron Life Sciences signs supply deal for medical cannabis study in the UK.
- University-backed programme in Somerset researches medical cannabis.
- Majority of Northern Irish students in favour of legalising medical cannabis.
- Britons can face deportation in the US if they consume cannabis, even in legal states.
- Global cannabis leaders gather for Cannabis Europa Toronto and New York.
- The worst is over for Canopy according to Bank of America.
- Aurora announces that CA$216 million of debentures have been converted to stock.
- Joe Biden calls for more research before backing cannabis legalisation.
- US cannabis deals are falling apart.
- Ontario to move towards private-sector distribution model.
- Report shows 44% of Florida’s patients prefer smoking medical cannabis.
- Health Canada officials overwhelmed with cultivation applications and site amendments.
Latam & Caribbean
- UK’s Eco-Equity receives medical cannabis licence in Antigua and Barbuda.
- MGC Pharma products to be sold in Brazil via financial service provider BrasilInvest.
- Both of Uruguay’s presidential candidates support current cannabis laws.
- Colombian cannabis producers struggling to meet pharmaceutical standards.
Health & Science
- UCLA awarded US$3.5 million grant to study cannabis as a treatment for pain.
- Research suggests daily cannabis use lowers odds of using opioids for chronic pain.
- Royal College of Psychiatrists says cannabis industry must fund further trials.
- Nearly 40% of US patients with rheumatic diseases use cannabis to treat symptoms.
- One in eight Australian women use cannabis to treat symptoms of endometriosis.
Spain represents Europe’s largest cannabis market yet to legalise medical cannabis. However, there is strong social support fueling a shift in the political debate. With 84% of the population in favour of medical cannabis, a burgeoning commercial industry and one of the most innovative biomedical sectors in the world, Spain is fast becoming the most promising industry in the region.
Join Cannabis Europa in early February at the Intercontinental Madrid to discuss the most pertinent questions for the Spanish and European industries.
The Global Cannabis Report
Prohibition Partners is proud to present The Global Cannabis Report, one of the most comprehensive studies ever completed on the international cannabis market.
The report predicts that the international cannabis market could be worth up to US$103.9 billion by 2024, and outlines key commercial opportunities for international operators and investors.
On the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.